A detailed history of Citigroup Inc transactions in Pfizer Inc stock. As of the latest transaction made, Citigroup Inc holds 5,445,198 shares of PFE stock, worth $150 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,445,198
Previous 6,359,640 14.38%
Holding current value
$150 Million
Previous $176 Million 13.67%
% of portfolio
0.1%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $23.1 Million - $27.1 Million
-914,442 Reduced 14.38%
5,445,198 $152 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $1.32 Million - $1.52 Million
51,090 Added 0.81%
6,359,640 $176 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $41.3 Million - $53.7 Million
1,580,936 Added 33.44%
6,308,550 $182 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $3.72 Million - $4.35 Million
-115,946 Reduced 2.39%
4,727,614 $157 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $16.1 Million - $18.6 Million
445,528 Added 10.13%
4,843,560 $178 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $29.9 Million - $39 Million
-759,913 Reduced 14.73%
4,398,032 $179 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $11.9 Million - $15.6 Million
285,485 Added 5.86%
5,157,945 $264 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $19.8 Million - $24.2 Million
453,462 Added 10.26%
4,872,460 $213 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $40.2 Million - $47.7 Million
-864,610 Reduced 16.36%
4,418,998 $232 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $59.6 Million - $73.9 Million
1,303,492 Added 32.75%
5,283,608 $274 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $23.6 Million - $34.9 Million
-570,588 Reduced 12.54%
3,980,116 $235 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $179 Million - $229 Million
4,550,704 New
4,550,704 $196 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.